Pharmafile Logo
Pharmafocus logo
Advanced Search

Q2

Showing 14 posts of 44 posts found.

Pfizer HQ

Pfizer looks to spin off animal health and nutrition

August 2, 2011
Sales and Marketing Pfizer, Q2, animal health, divestment, nutrition

Pfizer looks set to spin-off or sell its animal health and nutrition business units in order to focus on human …

News
Boehringer building at night

Generic competition hits Boehringer sales

August 9, 2010
Sales and Marketing 2010 financials, Boehringer, Q2

Boehringer Ingelheim’s sales fell 5% in the first half of 2010, depressed by generic competition and then further dragged down …

News

Victoza lifts Novo Nordisk

August 9, 2010
Sales and Marketing 2010 financials, Novo Nordisk, Q2

Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …

News

Wyeth acquisition boosts Pfizer results

August 4, 2010
Sales and Marketing 2010 financials, Pfizer, Q2

Pfizer’s second quarter results received a huge boost from the company’s multi-billion dollar acquisition of Wyeth last October. Sales of …

News

New products help lift UCB

August 3, 2010
Sales and Marketing 2010 financials, Q2, UCB

UCB’s newer products showed impressive growth in the first six months of this year, helping keep the Belgium-based biopharma firm’s …

News

Merck merger costs halve profits

August 2, 2010
Sales and Marketing 2010 financials, Merck & Co, Q2

Shares in Merck & Co fell as costs relating to the merger with Schering-Plough put a huge dent in second …

News

FDA recommends Brilinta

July 30, 2010
Sales and Marketing 2010 financials, AstraZeneca, Brillinta, Q2

FDA advisors have voted in favour of AstraZeneca’s antiplatelet drug Brilinta, which is currently seeking a licence for the reduction …

News

Sanofi’s blockbusters take a hit

July 29, 2010
Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis

Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …

News

Lonza boosts profit despite contract manufacturing downturn

July 23, 2010
Manufacturing and Production 2010 financials, Lonza, Q2

Switzerland’s Lonza posted a healthy increase in profits in the first half of 2010, topping analysts’ expectations, although sales dipped …

News

Roche sees slow sales amid market pressures

July 22, 2010
Sales and Marketing 2010 financials, Q2, Roche

Roche has posted average first half year results with pharma sales that showed only low single digit growth. They showed …

News

Abbott boosted by Solvay integration

July 22, 2010
Sales and Marketing 2010 financials, Abbott, Q2, Solvay

Abbott has posted a set of strong sales for the second quarter, buoyed by the integration of Solvay Pharmaceuticals and …

News
Genzyme

Manufacturing woes hit Genzyme results

July 22, 2010
2010 financials, Genzyme, Q2

Genzyme has posted a decrease in sales for the second quarter as its manufacturing woes continue. The US-based biopharma company …

News

Legal costs dent GlaxoSmithKline’s Q2

July 22, 2010
Medical Communications, Sales and Marketing 2010 financials, GlaxoSmithKline, Q2

GSK has reported a loss for its second quarter due to litigation costs related to Avandia and other problems. In …

News

J&J post modest second quarter increase

July 21, 2010
Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026